Coronavirus Host Entry

The entry of coronaviruses into susceptible host cells is mediated by the viral S (Spike) glycoprotein. This feed covers latest findings about this complex process and the ongoing research efforts into finding therapeutics that can target the viral Spike protein and hence disrupt virus-cell fusion.

August 6, 2020
Open Access

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Drug Design, Development and Therapy
Amin Sedokani, Sadegh Feizollahzadeh
August 6, 2020
Open Access

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Kui K ChanErik Procko
August 2, 2020

Tumor markers as an entry for SARS-CoV-2 infection?

The FEBS Journal
Pu Xia, Anna Dubrovska
August 6, 2020

Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein

Infectious Disorders Drug Targets
Bipin Singh
August 6, 2020
Open Access

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

Emerging Microbes & Infections
Cristina AndresJosep Quer
August 10, 2020
Open Access

COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Roger FrutosChristian A Devaux
August 2, 2020
Open Access

A thermostable, closed SARS-CoV-2 spike protein trimer

Nature Structural & Molecular Biology
Xiaoli XiongJohn A G Briggs
July 31, 2020
Open Access

Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library

The Journal of Biological Chemistry
Hilal Ahmed ParrayRajesh Kumar
July 29, 2020
Open Access

Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials

International Journal of Molecular Sciences
Rami A Al-HoraniKholoud F Aliter
July 31, 2020
Open Access

COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic

Diagnostic Microbiology and Infectious Disease
Stanley H Weiss, Gary P Wormser
August 1, 2020
Open Access

Design of an engineered ACE2 as a novel therapeutics against COVID-19

Journal of Theoretical Biology
Zahra PayandehSaeed Khalili
July 31, 2020
Open Access

Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Natesh SinghBruno O Villoutreix
July 30, 2020
Open Access

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Jingyun YangXiawei Wei
August 10, 2020

Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP

Mini Reviews in Medicinal Chemistry
Mohd Faheem, Vinay K Singh
July 29, 2020
Open Access

Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry

BioRxiv : the Preprint Server for Biology
J. Aguilar PinedaChristian L Lino Cardenas

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2020 Meta ULC. All rights reserved